Remynd

This study tested a new oral medication called REM0046127 for people with mild to moderate Alzheimer's disease. It aimed to see if the drug could affect certain markers in the brain fluid and was safe to take. Participants took either the drug at a high or low dose or a placebo f…

This was an early-stage study to check the safety of a new oral medicine called REM0045392, which is being developed to treat Alzheimer's disease. It involved 19 healthy men and older adults who took single or multiple doses over 14 days. The main goal was to see how the body pro…